Annalisa Ruggeri received her Medical degree from University of Messina, Italy, in 2004.   She completed her Hematology residency at the San Raffaele Vita-Salute University, Milano, Italy in 2008, and the PhD in Hematology in 2014.  In 2007 she was awarded the EBMT-AMGEN fellowship at the Hospital Saint Louis in Paris, France. She was staff member at the Hematology Department at the Saint Antoine Hospital in Paris, France and at Pediatric Hemato-oncology and cell and Gene therapy Department at the Ospedale Bambino Gesù in Roma, Italy.

Since February 2020 she is senior physician at the Hematology and Bone Marrow Transplant unit of the San Raffaele Scientific Institute in Milano, Italy. Focus of research is mainly on results and risk factors of alternative donor transplants, haploidentical and cord blood transplantation, GVHD, use of cellular therapy and targeted therapy. She is active in clinical research activities being scientific chair of the Eurocord office in Paris since 2012, and secretary of the Cellular therapy and Immunobiology working party of the European society of Blood and Marrow transplantation (EBMT) since 2018. She is member of the ISCT- Stem cell source and graft engineering Committee. She is author of more than 200 peer-reviewed publications (H-index 44, Scopus 2021) and has participated as invited speaker of many international conferences such American Society of Hematology (educational sessions), European society of Hematology and EBMT, ESH, ISCT, TCT.